The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Guardant Health Inc. | COM | 40131M109 | 1,597,352 | 22,950,460 | SH | DFND | 0 | 22,950,460 | 0 | ||
| Slack Technologies Inc. | COM CL A | 83088V102 | 466,038 | 17,363,549 | SH | DFND | 0 | 17,363,549 | 0 | ||
| Uber Technologies Inc. | COM | 90353T100 | 6,204,611 | 222,228,178 | SH | DFND | 0 | 171,664,743 | 50,563,435 | ||
| VIR Biotechnology Inc. | COM | 92764N102 | 775,073 | 22,616,666 | SH | DFND | 0 | 22,616,666 | 0 | ||
| 10X Genomics Inc. | CL A COM | 88025U109 | 239,074 | 3,836,232 | SH | DFND | 0 | 3,836,232 | 0 | ||